Tau phosphorylation is widely recognized as important to the aggregation of Tau, and thus to AD pathology.5 We note that phosphorylation of Tau T231 was the most confident differentially abundant PTM observed, followed by the Tau crosslink between S262-C291 (Fig. 4A). This evidence concerns the gene MAPT and Alzheimer disease.